Oligonucleotides active against drug-resistant bacteria

Abstract

The invention discloses methods and materials for the utilization of chemically modified oligonucleotides in the treatment of drug-resistant bacterial infections including drug-resistant tuberculosis.

Claims aren’t available for this document.